ArticleScientific reports2025
Smart green spectrophotometric estimation and content uniformity testing of chlorphenoxamine HCl and caffeine in bulk forms and combined pharmaceutical formulation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlorphenoxamine hydrochloride is a chemical that has attracted interest because of its notable anti-histaminic and anti-cholinergic characteristics. Moreover, it has been recognized as a highly efficient tool in the fight against several lethal viral diseases, such as Severe Acute Respiratory Syndrome Coronavirus. In this study, five efficient and straightforward univariate spectrophotometric approaches are proposed for accurately measuring the quantities of Caffeine and Chlorphenoxamine HCl in bulk forms and combined pharmaceutical formulations. Notably, these methods based on an advanced approach using the factorized response spectrum and not require any initial processing.They have been classified into three spectrophotometric platform windows. The study of Window I focuses on absorption spectra of substances in their original states(zero-order). It includes, absorbance resolution method (AR), extended absorbance difference method (EAD), and factorized zero order method (FZM). Window II focuses on the factorized derivative method (FDM), while Window III focuses on factorized ratio difference method (FRM). These approaches successfully measured concentration of Caffeine and Chlorphenoxamine HCl within a range of 3-35.0 and 3-45.0 μg/mL, respectively. The factorized response spectrum's exclusivity stems from its capacity to fully separate the mentioned components in mixture and recover the pure spectra. Validation of the suggested approaches has been conducted according to guidelines established by International Council for Harmonization, which demonstrated acceptable levels of accuracy and precision. The scope of this work has been expanded to include verification of content uniformity of dosage units according to recommendations outlined in United States Pharmacopoeia. Greenness profile of the proposed approaches has been properly assessed using state-of-the-art software metrics, in comparison to the reported one. Finally, the proposed methods demonstrated strong compliance with the recently established principles of white field of analytical chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.